Key result
Levothyroxine with heart failure therapy resolves ventricular arrhythmias and normalizes LVEF in severe hypothyroidism.
Why the study?
Hypothyroidism is typically associated with bradyarrhythmias, but can rarely precipitate life-threatening ventricular arrhythmias.
Case Report (n=1)
No
This case demonstrates that severe undiagnosed hypothyroidism can manifest as life-threatening polymorphic ventricular tachycardia and reversible left ventricular dysfunction, both of which can completely resolve with levothyroxine replacement and heart failure therapy without requiring long-term antiarrhythmic drugs.
Answers are grounded in this paper and cite their sources.
Supports hypothyroidism screening in unexplained polymorphic VT with reduced LVEF; leaves open generalizability beyond this single case.
Hypothyroidism is typically associated with bradyarrhythmias, but can rarely precipitate life-threatening ventricular arrhythmias. We present a case of severe hypothyroidism manifesting as polymorphic ventricular tachycardia (VT). A previously healthy woman in her early 50s presented with an acute onset of breathlessness and on examination had hypotension and tachycardia. ECG revealed polymorphic VT, promptly terminated by defibrillation using 200J biphasic shock. Investigations uncovered severe primary hypothyroidism (thyroid-stimulating hormone: 142 mIU/l) and left ventricular (LV) dysfunction with ejection fraction (EF) of 35%. Coronary angiogram was normal. Treatment with levothyroxine and standard heart failure therapy was initiated. In conclusion, at 3- and 6-month follow-ups, the patient remained asymptomatic and had no episodes of tachyarrhythmias without antiarrhythmic drugs, and her LV function normalized (EF: 55%). This case highlights the importance of considering hypothyroidism in patients presenting with unexplained ventricular arrhythmias.
No takes yet. Share an insight, caveat, or question.
Waddankeri et al. (2025) conducted a case report in Polymorphic ventricular tachycardia and severe primary hypothyroidism with LV dysfunction (LVEF 35%) (n=1). Defibrillation (200 J biphasic shock), IV magnesium sulfate, levothyroxine replacement, and standard heart failure therapy was evaluated on Recurrence of ventricular tachyarrhythmias and left ventricular ejection fraction recovery at 6 months. Levothyroxine and heart failure therapy resolved ventricular arrhythmias and normalized left ventricular ejection fraction from 35% to 55% at 6 months in a patient with severe hypothyroidism.
Synapse has enriched 10 related papers. Consider them for comparative context: